Robeco QI Global Conservative Equities D €
Sub-fund of Robeco Capital Growth Funds (SICAV domiciled in Luxembourg)
Fund is the popular name for UCI (Undertaking for Collective Investment). A UCI is an undertaking that brings together several investors and invests their deposited money in various investment products, such as stocks, bonds, cash, etc., in order to spread the risk.
Before you proceed with investing, you must read and evaluate the KIID and prospectus. The KIID sets out the objectives, investment policy, risks and benefits, and costs and past performance of the fund.
Source NAV www.beama.be
KEY INFORMATION
LEGAL DOCUMENTS
PERFORMANCE
ANALYSIS

Fund Profile

Category: SICAV

Robeco QI Global Conservative Equities is an actively managed fund that invests in low-volatility stocks in developed and emerging countries across the world. The selection of these stocks is based on a quantitative model. The fund's long-term aim is to achieve returns equal to, or greater than, those on global equity markets with lower expected downside risk. The selected low-risk stocks are characterized by high dividend yields, attractive valuation, strong momentum and positive analyst revisions as well. This results in a diversified, low turnover portfolio of defensive stocks aiming to achieve stable equity returns and high income. Currency risk will not be hedged. Exchange-rate fluctuations will therefore directly affect the fund's share price. Benchmark: MSCI All Country World Index (Net Return, EUR) The majority of stocks selected through this approach will be components of the benchmark, but stocks outside the benchmark index may be selected too. The fund can deviate from the weightings of the benchmark. The fund aims to outperform the benchmark over the long run, whilst still controlling relative risk through the applications of limits (on countries and sectors) to the extent of deviation from the benchmark. This will consequently limit the deviation of the performance relative to the benchmark. This share class of the fund does not distribute dividend. You can purchase or sell units in the fund on any valuation day. This fund may not be appropriate for investors who plan to withdraw their money within 5 years.

Risk Profile
Significant risks that are not adequately reflected in the profile:

Chinese investment risk
Due to special regulation in China, this fund may experience difficulties or delays in enforcing the rights.

You will find all other risks associated with this fund in the prospectus.
Morningstar Rating
More information about the calculation of the Morningstar Ratings
Bronze
Bronze
Risk and reward profile
1
2
3
4
5
6
7
Lower Risk
Possible Lower
Returns
Higher Risk
Possible higher
Returns
Key Information
Closing Price 24/09/2021 246.92
Morningstar category Global Large-Cap Blend Equity
Currency EUR
Distribution status Capitalizing
ISIN LU0705782398
Inception Date 13/12/2011
Maturity date Unlimited
Management strategy (vs benchmark) Active
Minimum initial amount 100.00 EUR
Fees And Charges
Entry fee None
Tax on entry None
Custody fees None
Tax on returns
No
Tax on dividend N/A
Exit fee None
Tax on exit 1.32 (max. 4,000.00 EUR per fund)
Ongoing charge 1.21% of which 0.50% is paid to MeDirect
Fund management company
Address Robeco Institutional Asset Mgmt BV Weena 850 Rotterdam 3014 DA Netherlands
Manager Name Jan Sytze Mosselaar
Manager Start Date 14/12/2014
Website www.robeco.com
Total Net Assets (mil) 389.52 EUR (31/08/2021)
UCITS Yes
Administrator J.P. Morgan Bank Luxembourg S.A.

Legal Documents

It is possible that this fund applies swing pricing. Please consult the prospectus for more information.
Should you have any complaints, you may contact Compliance Officer MeDirect, Keizerinlaan 66, 1000 Brussel or via [email protected] or Ombudsfin, Ombudsman for financial disputes, North Gate II, Koning Albert II – laan 8 bus 2, 1000 Brussel or via [email protected]

Performance

Historical returns returns and the evolution of the NAV are no guarantee for future performances. Investing in Financial markets and securities involves risk. Past performance is not a guarantee of future results. Investment losses may occur and investors could lose some or all of their investment in the Fund.
Sales charges (like entry- and exit fees ) and taxes are not included in the calculation of past performance. Management fees, administrative fees and other costs taken out of the fund assets have been taken in to account, as they are already included in the NAV.
Annualised performance in EUR
PeriodAnnualised returnDate
1 year21.55%24/09/2021
3 years6.96%24/09/2021
5 years5.90%24/09/2021
Since launch9.68%24/09/2021
Cumulative performance in EUR
Performance
YTD 01/01/202116.70
1 month-1.41
3 months3.84
6 months10.17
Quarterly Returns
Q 1Q 2Q 3Q 4
20218.15%4.77%--
2020-20.61%8.55%0.46%2.71%
201913.13%2.63%6.34%1.96%
2018-3.82%3.28%4.84%-7.43%
20174.19%-2.63%-1.55%2.50%

Analysis

Asset Allocation
% Long% Short% Net Assets
Stock98.54%0.00%98.54%
Bond0.00%0.00%0.00%
Cash4.04%3.27%0.76%
Other0.70%0.00%0.70%
Return/Risk Analysis
Risk Measurement1 Year3 Years5 Years
Standard Deviation
10.5515.1812.34
Sharpe Ratio
1.680.490.55
Sortino Ratio
4.180.640.73
Positive Months9.0024.0035.00
Negative Months3.0012.0025.00
Worst Month-2.53-15.02-15.02
World Regions
Region%
United States48.88
Europe - ex Euro8.98
Asia - Developed8.86
Canada7.75
Australasia6.20
Japan3.51
Eurozone3.35
Asia - Emerging3.33
United Kingdom3.22
Europe - Emerging2.66
Latin America1.57
Middle East0.23
Stock Sector Weighting
Sector% of Equity
Financial Services18.93
Technology16.16
Consumer Defensive
15.80
Communication Services11.65
Healthcare10.86
Consumer Cyclical
7.93
Industrials7.09
Basic Materials4.51
Utilities2.55
Real Estate2.29
Energy0.78
Top 10 Holdings
HoldingSectorCountry% of Assets
Microsoft Corp TechnologyUnited States3.03
Apple Inc TechnologyUnited States2.97
Johnson & Johnson HealthcareUnited States2.04
Cisco Systems Inc TechnologyUnited States2.03
Pfizer Inc HealthcareUnited States2.03
Procter & Gamble Co Consumer DefensiveUnited States2.01
Walmart Inc Consumer DefensiveUnited States1.99
The Home Depot Inc Consumer CyclicalUnited States1.98
Target Corp Consumer DefensiveUnited States1.97
Merck & Co Inc HealthcareUnited States1.97
It is possible that some UCI presented in the portfolio are not offered in Belgium, please verify with our client service
Classification of Morningstar Category
Ranking1 Year2 Years3 Years5 Years
Top 25%
Category above the average
Category below the average
Bottom 25%
Morningstar Style Box
Equity Style
Large
Size
Mid
Small
Value
Blend
Growth
Style
All key information and documents must be reviewed before being able to Invest.